All In Biotech

Drug Trial Radar · NCT04523935

Excessive Crying in Children With Cerebral Palsy and Communication Deficits

Excessive Crying in Children With Cerebral Palsy and Communication Deficits -a Fixed-sequence, Crossover Clinical Trial

Last checked: Nov 20, 2026Latest source record: Oct 28, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

131

Actual

Start

Dec 7, 2005

Primary completion

Aug 4, 2020

Study completion Aug 4, 2020

Sponsor

Lead sponsor
Sathbhavana Brain ClinicAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 24, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Crossover
Masking
Triple (participant, care provider, outcomes assessor)
Primary purpose
Supportive care
FDA-regulated drug
No
Who can join
All sexes, up to 15 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Management of excessive crying in children with cerebral palsy and communication deficits \[ECCCPCD\] was guided by the associated clinical findings and investigations.

Conditions

  • Cerebral Palsy
  • Excessive Crying
  • Pain

Interventions

  • PlaceboOther

    Fructose powder identical with the drugs was used

  • Baclofen, Diazepam, Clonazepam, Trihexyphenidyl, Tetrabenazine, Gabapentin, Topiramate, Lamotrigine, Amitriptyline.Drug

    Drugs were used either singly or in combination guided by clinical findings and investigations.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Epidemiologic data (Age and sex).Time frame: 400 days.
  2. The Gross Motor Function Classification System (GMFCS) levelsTime frame: 400 days
  3. The Modified Ashworth Scale (MAS) scoresTime frame: 400 days
  4. Measurement of both Total and Unexplained cry durationsTime frame: 400 days

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.